Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
35.95
-1.06 (-2.88%)
Sep 14, 2026, 3:22 PM EDT - Market open
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.85 billion as of September 14, 2026. Its market cap has increased by 297.86% in one year.
Market Cap
1.85B
Enterprise Value
1.90B
1-Year Change
297.86%
Ranking
Category
Stock Price
$35.95
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.85B, an increase of 236.18%. That is a compound annual growth rate of 23.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.85B | 66.65% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vericel | 1.96B |
| Biohaven | 1.92B |
| Stoke Therapeutics | 1.87B |
| GH Research | 1.87B |
| Zymeworks | 1.86B |
| Hemab Therapeutics Holdings | 1.84B |
| Xencor | 1.81B |
| Kailera Therapeutics | 1.81B |